LDL Receptor Deletion Increases Amyloid Plaque Formation in Alzheimer's Disease Mouse Model
Author Information
Author(s): Katsouri Loukia, Georgopoulos Spiros, Block Michelle L.
Primary Institution: Biomedical Research Foundation of the Academy of Athens, Athens, Greece
Hypothesis
Does the deletion of the LDL receptor (LDLR) affect amyloid deposition in an Alzheimer's disease mouse model?
Conclusion
The study found that LDLR deficiency leads to increased amyloid plaque deposition and decreased glial response in an Alzheimer's disease mouse model.
Supporting Evidence
- LDLR deficiency was associated with increased amyloid plaque deposition in the brains of transgenic mice.
- Astrocytic and microglial responses were significantly reduced in LDLR deficient mice.
- The study demonstrated that LDLR regulates glial response independently of ApoE.
Takeaway
When scientists removed a specific receptor from mice that model Alzheimer's disease, they found more sticky plaques in the brain and less response from brain helpers called glial cells.
Methodology
The study used APP/PS1 transgenic mice to investigate the effects of LDLR deletion on amyloid deposition and glial response.
Participant Demographics
4 months old female mice
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website